scholarly article | Q13442814 |
P50 | author | F Gelsomino | Q53282053 |
Giuseppe Lamberti | Q87977490 | ||
P2093 | author name string | Andrea Ardizzoni | |
Michelangelo Fiorentino | |||
Claudio Borghi | |||
Barbara Melotti | |||
Mauro Gargiulo | |||
Francesca Sperandi | |||
Stefano Brocchi | |||
Antonio Poerio | |||
P2860 | cites work | Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. | Q34582934 |
Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation | Q35013382 | ||
PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis | Q35649732 | ||
Increased Risk of Herpes Zoster in Diabetic Patients Comorbid with Coronary Artery Disease and Microvascular Disorders: A Population-Based Study in Taiwan | Q35889877 | ||
Inflammation and immune system interactions in atherosclerosis | Q38083555 | ||
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. | Q40067370 | ||
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity | Q40163840 | ||
Increased risk of cardiovascular events in patients with herpes zoster: a population-based study | Q44883715 | ||
Adverse Events in Cancer Immunotherapy | Q46884498 | ||
Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques? | Q50140953 | ||
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis | Q56888890 | ||
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q57051777 | ||
Cancer statistics, 2019 | Q90941571 | ||
Hepatotoxicity and Recurrent NSTEMI While on Pembrolizumab for Metastatic Giant Cell Bone Tumor | Q91027542 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 1758835920913801 | |
P577 | publication date | 2020-07-24 | |
P1433 | published in | Therapeutic advances in medical oncology | Q26842113 |
P1476 | title | New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event | |
P478 | volume | 12 |
Search more.